University of Chicago

RUBIN LAB

University of Chicago

RUBIN LAB

Our Team

University of Chicago

RUBIN LAB

Section of Gastroenterology, Hepatology and Nutrition

Inflammatory Bowel Disease Center

MISSION STATEMENT FOR THE RUBIN LAB

The Rubin Lab seeks to improve the lives of patients with inflammatory bowel disease through the pursuit of innovative clinical research exploring disease prevention, diagnosis, monitoring and management.

“The patient who is suffering is at the center of everything we do”

RUBIN LAB

David T. Rubin, MD, specializes in the treatment and assessment of digestive diseases. His clinical expertise includes inflammatory bowel diseases (Crohn’s disease and ulcerative colitis) and high-risk cancer syndromes.

RESEARCH

Find out about recent publications and ongoing clinical trials.

Rubin Lab at Digestive Disease Week 2025

Dr. Alvin George presented on applications of machine learning models in IBD

Khushi Bhondwe and Charlotte Duty presented on the association of mild hyperemia and biochemical disease activity despite the absence of bowel wall thickening on intestinal ultrasound

Alexandra McDermott presented on the clinical and biochemical effectiveness of dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn’s disease

Dr. Meredith Kline presented on the incidence and prophylaxis of VTE in pediatric patients with IBD

Dr. Asher Shafrir presented on the association between anti-TNF therapy and reduced risk of diabetes in patients with IBD

Jordan Karpin presented on the differences in depression, anxiety, and microbiome among female patients with IBD in two phases of the menstrual cycle

Dr. Agnes Ho presented on the real world experience of upadacitinib reinduction and high dose maintenance therapy to recapture disease response in IBD